Latest News

Iron chelation drug used to treat rare, devastating neurodegenerative disease in children

A promising pilot study of deferiprone for the treatment of the neurodegenerative disorder, PKAN, leads to an international trial with potential implications for Parkinson?s and other neurodegenerative diseases.
View full story

Post your comment.


  • Amblyopia, not strabismus, identified as key contributor to slow reading in school-age children

  • Visual stress could be a symptom of Chronic Fatigue Syndrome, research suggests

  • Lower availability of omega-3 fatty acids in the body associated with bipolar disorder

  • Rats: Sniff and track, or run and scan?

  • Two-thirds of studies on 'psychosocial' treatments fail to declare conflicts of interest

  • New protein biomarker identifies damaged brain wiring after concussion

  • Fruit flies provide new insight into body's rhythms

  • High-fat diet prompts immune cells to start eating connections between neurons

  • Want to remember new names? Sleep on it

  • Adults aged 50-59 now largest age group in opioid treatment programs